InvestorsHub Logo
Followers 8
Posts 191
Boards Moderated 0
Alias Born 04/30/2014

Re: None

Tuesday, 08/04/2015 11:11:57 AM

Tuesday, August 04, 2015 11:11:57 AM

Post# of 9772
I expect more analyst coverage to start for SNGX with this second Orphan Drug designation. This reminds me of FCSC who also got a second Orphan drug designation and also has R.J. Kirk involved. Orphan drug designation by the FED makes it a huge takeout target from big pharma due to exclusivity... LONG every R.J. Kirk stock including SNGX! Patient investors will double or triple from here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNGX News